Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation

Background and Aim: Several pre-clinical and clinical researches have proved that obeticholic acid (OCA)has a potential therapeutic effect on non-alcoholic steatohepatitis (NASH). Our aim was to investigate whether the therapeutic effect of OCA on NASH was attributed to its inhibition effect on cyto...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Clin Exp Pathol
Asıl Yazarlar: Yang, Zhi-Yu, Liu, Feng, Liu, Pei-Hao, Guo, Wan-Jun, Xiong, Guo-Yu, Pan, Hai, Wei, Lai
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965461/
https://ncbi.nlm.nih.gov/pubmed/31966664
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller